Recro
Information
Recro(R) provides oral solid dosage form development, regulatory support, clinical and commercial manufacturing, and packaging and logistics services to the global pharmaceutical market. Specializing in modified release oral solid dose and DEA controlled substances, Recro has the experts to deliver clients' most complex pharmaceutical development, manufacturing, and packaging projects in its best-in-class, 120,000-square-foot manufacturing facility. For more information about Recro's flexible CDMO solutions, visit www.recrocdmo.com.
Country
United States
Company Type
Manufacturer/Innovator
Exhibitor Access Type
In-Person & Online
Booth Location
2237
Offering
Offering: Markets Active in
OceaniaNorth America (USA, Canada)AfricaMiddle East Region (e.g. UAE)Central America (e.g. Mexico)East Asia (e.g. China, Japan, Korea)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)South America (e.g. Brazil, Colombia)South Asia (e.g. India, Pakistan, Sri Lanka)South East Asia (e.g. Thailand, Philippines, Singapore)
Offering: Contract Services
Contract ManufacturingFormulation development
Offering: Custom Manufacturing
Custom Manufacturing of Dosage Form Drugs
Offering: Finished Dosage
CapsulesTablets
Offering: Pharmaceutical Packaging
Primary Packaging
Offering: Pharmaceutical Machinery & Technology
Drug Formulation (general category)Pharmaceutical Technology (general category)
Offering: Products or Services
Custom ManufacturingFinished Dosage FormsPharmaceutical PackagingContract ServicesPharmaceutical Machinery & Technology
